Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000277.2(PAH):c.331C>T (p.Arg111Ter)

CA251526

581 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: a0f4f502-3d14-496e-92b6-b2160d5d9013

Approved on: 2019-04-09

Published on: 2019-04-09

HGVS expressions

NM_000277.2:c.331C>T

NM_000277.2(PAH):c.331C>T (p.Arg111Ter)

NC_000012.12:g.102894756G>A

CM000674.2:g.102894756G>A

NC_000012.11:g.103288534G>A

CM000674.1:g.103288534G>A

NC_000012.10:g.101812664G>A

NG_008690.1:g.27847C>T

NG_008690.2:g.68655C>T

NM_000277.1:c.331C>T

NM_001354304.1:c.331C>T

NM_000277.3:c.331C>T

ENST00000307000.7:c.316C>T

ENST00000546844.1:c.331C>T

ENST00000548928.1:n.253C>T

ENST00000549111.5:n.427C>T

ENST00000550978.6:n.315C>T

ENST00000551337.5:c.331C>T

ENST00000551988.5:n.420C>T

ENST00000553106.5:c.331C>T

Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"

PP4_Moderate PVS1 PM3_Very Strong

PM2

Evidence Links 5

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

PAH-specific ACMG/AMP criteria applied: PVS1: Nonsense variant; PP4_Moderate: Seen in multiple Chinese PKU patients. BH4 deficiency excluded. (PMID:1301187; PMID:2816939; PMID:9860305); PM3_very-strong: Detected in trans with 6 known pathogenic variants: p.R158Q; p.R241C; p.R243Q; p.E280K; p.Y356*; p.R413P (PMID:15503242, 26322415). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PP4_Moderate, PM3_very-strong).

PP4_Moderate

Seen in multiple Chinese PKU patients. BH4 deficiency excluded.

Detected 3 times in Japanese patients with PKU. Patients with BH4 deficiency were excluded based on the absence of neurologic deterioration on a low phenylalanine diet, analysis of dihydropteridine reductase activity in red blood cells, biopterin loading test, and/or pteridine analysis of urine. PubMed:9860305

R111X is seen in 9.1% of Chinese PKU patients associated with haplotype 4. Wang et al. 1989. PubMed:1301187

An Arg111-to-Ter111 mutation has been identified in exon 3 of the PAH gene in a Chinese PKU patient. Classic, severe PKU was confirmed by Guthrie test and clinical criteria with plasma Phe level > 20 mg/dl. 2 other PKU patients had R111Ter, and an additional 5 alleles were identified with haplotype 4, and an additional 5 patients without haplotyping data. PubMed:2816939

PVS1

Nonsense variant

PM3_Very Strong

Detected with: p.R158Q (P, 11 submitters); p.R241C (P, 7 submitters); p.R243Q (P, 7 submitters); p.E280K (P, 9 submitters); p.Y356* (P, 5 submitters); p.R413P (P, 6 submitters)

Detected in 13 patients with: c.611A>G, p.E280K, p.Y356*, p.V399V, p.Y154H, p.R158Q, p.R241C, p.R243Q, p.G307D, p.A322T, p.I324N, p.R413P. All mutations identified in patients were confirmed by analyzing parental DNA. When mutation loci were detected in patients, the same locus of the parental sample was amplified by PCR and analyzed by Sanger automated sequencing. PubMed:26322415

Patient 29: R111X/R243Q (VarID591, Pathogenic) PubMed:15503242

PM2

Absent from 1000G, ESP. ExAC MAF=0.00029.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.